R&D

future forward-looking 2026 new year
Biotech

Pharma's 'urgent need for reinvention': PwC's call to action

PwC has laid out bold ambitions for what it believes drugmakers could achieve by 2035, as well as steps those companies should start taking in 2026.
Fraiser Kansteiner Jan 8, 2026 6:00am
person throwing away garbage or recycling

After $4.8B Amicus buy, BioMarin drops genetic disease asset

Dec 22, 2025 11:12am
Saplings growing with increasing denominations of money wrapped around them

FDA's 1-trial approval plan would boost R&D spend: Jefferies

Dec 5, 2025 11:00am
layoffs cuts workforce reduction chairs boxes fired

Valneva closes site to consolidate R&D footprint, lays off 30

Nov 26, 2025 12:57pm
Glow keyhole abstract futuristic technology background

Value of AI biotechs nearly double that of peers: PitchBook

Nov 26, 2025 10:34am
Aerial view of Montreal Old Port in autumn

AbbVie seeks biotech applicants for Canadian innovation award

Nov 25, 2025 12:00pm